Shares of Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) traded down 0.4% during mid-day trading on Friday . The company traded as low as $0.23 and last traded at $0.23. 200 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 20,393 shares. The stock had previously closed at $0.23.
Alpha Tau Medical Price Performance
The firm has a 50-day simple moving average of $0.21 and a two-hundred day simple moving average of $0.25.
About Alpha Tau Medical
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.
See Also
- Five stocks we like better than Alpha Tau Medical
- What is the MACD Indicator and How to Use it in Your Trading
- Meta’s 5 Key Pillars for AI Growth—Zuckerberg’s Bold Vision
- How to Capture the Benefits of Dividend Increases
- Retail Investors Are Betting Big on Rocket Lab—Should You Too?
- How to Evaluate a Stock Before Buying
- GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
